Researcher
Thomas Demuyser
- Keywords:Pharmacy and pharmacology, Medicine
- Disciplines:Other translational sciences not elsewhere classified, Other pharmaceutical sciences not elsewhere classified, Other basic sciences not elsewhere classified, Human and medical genetics not elsewhere classified, Other clinical sciences not elsewhere classified
Affiliations
- Artificial Intelligence supported Modelling in clinical Sciences (Research group)
Member
From1 Jul 2021 → Today - Supporting clinical sciences (Department)
Member
From1 May 2023 → Today - Clinical sciences (Department)
Member
From3 Jul 2021 → 20 Oct 2022 - Clinical sciences (Department)
Member
From1 Jul 2021 → Today - Medicine and Pharmacy academic/administration (Office)
Member
From1 Dec 2020 → 14 Nov 2022 - Medicine and Pharmacy academic/administration (Office)
Member
From1 Dec 2020 → 2 Jul 2021 - Clinical Biology (Department)
Member
From1 Mar 2019 → 28 Jan 2024 - Faculty of Medicine and Pharmacy (Faculty)
Member
From17 Aug 2018 → 13 Sep 2020 - Clinical Biology (Department)
Member
From1 Jan 2017 → 31 Aug 2017 - Faculty of Medicine and Pharmacy (Faculty)
Member
From10 Aug 2015 → 14 Oct 2016 - Pharmaceutical and Pharmacological Sciences (Department)
Member
From1 Jan 2014 → 31 Dec 2016 - Experimental Pharmacology (Research group)
Member
From1 Oct 2012 → 22 Mar 2024 - Pharmaceutical Chemistry, Drug Analysis and Drug Information (Department)
Member
From1 Oct 2012 → 31 Dec 2013 - Faculty of Medicine and Pharmacy (Faculty)
Member
From13 Aug 2010 → 29 Jun 2012
Projects
1 - 1 of 1
- Joint R&D 2023: The development of an app-based lifestyle intervention to tackle pain, inflammation and gut microbiome disturbances in patients with chronic low back painFrom1 Aug 2023 → 17 Nov 2023Funding: Brussels Capital Region
Publications
11 - 20 of 44
- Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates(2023)
Authors: Robin Vanstokstraeten, Denis Piérard, Florence Crombé, Deborah De Geyter, Ingrid Wybo, Astrid Muyldermans, Lucie Seyler, Ben Caljon, Toon Janssen, Thomas Demuyser
- Intestinal helminthic infections(2023)
Authors: M Vanhooren, A Stoefs, S. Van Den Broucke, Marjan Van Esbroeck, Thomas Demuyser, Sébastien Kindt
Pages: 460-473 - Culturomics in Unraveling the Upper Female Reproductive Tract Microbiota(2023)
Authors: Robin Vanstokstraeten, Thomas Demuyser, Denis Piérard, Ingrid Wybo, C. Blockeel, Shari Mackens
Pages: 151-159 - Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts(2022)
Authors: Louis Nevejan, Sien Ombelet, Lies Laenen, Els Keyaerts, Thomas Demuyser, Lucie Seyler, Oriane Soetens, Els Van Nedervelde, Reinout Naesens, Dieter Geysels, et al.
- Culturomics to investigate the Endometrial Microbiome: Proof-of-Concept(2022)
Authors: Robin Vanstokstraeten, S Mackens, Ellen Callewaert, Susanne Blotwijk, Kristof Emmerechts, Florence Crombé, Oriane Soetens, Ingrid Wybo, Kristof Vandoorslaer, Laurence Evelyne Mostert, et al.
Pages: 1-21 - Healthcare-Associated COVID-19 across Five Pandemic Waves(2022)
Authors: Thomas Demuyser, Lucie Seyler, Rhea Buttiens, Oriane Soetens, Els Van Nedervelde, Ben Caljon, Jessy Praet, Thomas Seyler, Joost Boeckmans, Jessy Meert, et al.
- Healthcare-Associated SARS-CoV-2 Reinfection after 3 Months with a Phylogenetically Distinct Omicron Variant(2022)
Authors: Kim Callebaut, A Stoefs, Dimitri Stylemans, Oriane Soetens, Florence Crombé, Ellen Vancutsem, Hideo Imamura, Ingrid Wybo, Deborah De Geyter, Denis Piérard, et al.
- Validation of the Colibrí Instrument for Automated Preparation of MALDI-TOF MS Targets for Yeast Identification(2022)
Authors: Robbe Heestermans, Pauline Herroelen, Kristof Emmerechts, Kristof Vandoorslaer, Deborah De Geyter, Thomas Demuyser, Ingrid Wybo, Denis Piérard, Astrid Muyldermans
Pages: 1-7 - External Quality Assessment of SARS-CoV-2 Sequencing(2022)
Authors: Fanny Wegner, Tim Roloff, Michael Huber, Samuel Cordey, Alban Ramette, Yannick Gerth, Claire Bertelli, Madlen Stange, Helena M B Seth-Smith, Alfredo Mari, et al.
- A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines(2021)
Authors: Robin Vanstokstraeten, Nassiba Belasri, Thomas Demuyser, Florence Crombé, Kurt Barbé, Denis Piérard
Pages: 2371-2377